본문으로 건너뛰기
← 뒤로

European Code Against Cancer, 5th edition - a tool for enhancing cancer prevention.

Molecular oncology 2026 Vol.20(1) p. 3-5

Schüz J, Espina C, Weiderpass E, Nagy P

📝 환자 설명용 한 줄

The European Code Against Cancer (ECAC) provides evidence-based public health recommendations to reduce cancer risk across Europe.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Schüz J, Espina C, et al. (2026). European Code Against Cancer, 5th edition - a tool for enhancing cancer prevention.. Molecular oncology, 20(1), 3-5. https://doi.org/10.1002/1878-0261.70190
MLA Schüz J, et al.. "European Code Against Cancer, 5th edition - a tool for enhancing cancer prevention.." Molecular oncology, vol. 20, no. 1, 2026, pp. 3-5.
PMID 41542808

Abstract

The European Code Against Cancer (ECAC) provides evidence-based public health recommendations to reduce cancer risk across Europe. First launched in 1987, it is periodically updated mainly to reflect scientific advances. The 5th edition (ECAC5), released for the medical oncology community in 2025 and to be presented to the public in 2026, aims to offer an authoritative and practical tool for cancer prevention for individuals and policymakers. Developed by over 60 experts across five Working Groups, ECAC5 expands the 12 recommendations of the 4th edition to 14, incorporating the latest evidence on modifiable cancer risks and effective medical interventions. Key innovations include new guidance on air pollution, cancer-related infections, lung cancer screening and strengthened recommendations on tobacco, alcohol, diet, body weight, and occupational and radiation exposures. A major advancement is the addition of dedicated policy recommendations, acknowledging that many prevention measures require supportive environments and regulation. By aligning cancer prevention with broader noncommunicable disease strategies, ECAC5 aims to enhance uptake and impact. Its effective implementation could prevent up to 40% of new cancers in the EU.

MeSH Terms

Humans; Europe; Neoplasms

같은 제1저자의 인용 많은 논문 (1)